Age-specific patterns of hallucinogen use in the US population: an analysis using generalized additive models
- PMID: 9023070
- DOI: 10.1016/s0376-8716(96)01297-5
Age-specific patterns of hallucinogen use in the US population: an analysis using generalized additive models
Abstract
Although there has been growing concern in recent years about an escalation in the use of LSD and other hallucinogens, little is known about the distribution of the use of these drugs in the United States population. In order to fill this gap, we used generalized additive models to analyze data from the 1988, 1990, and 1992 National Household Survey on Drug Abuse, to compare the age-specific prevalence of hallucinogen use by level of socio-economic indicators. In addition, we used survival analysis to compare patterns in the onset of use. Use of hallucinogens in the past year was highest at the age of 19 years for each of the NHSDA surveys, but use was not linked to enrollment in school at this age. Past year prevalence was highest among whites and respondents with high family income. The onset of hallucinogen use was most likely to occur between ages 15-19 years, regardless of birth cohort. These results indicate a stable pattern since hallucinogens were made widely available in the late 1960s, in which the transition from adolescence to adulthood has been the period of highest risk for hallucinogen use.
Similar articles
-
Who is becoming hallucinogen dependent soon after hallucinogen use starts?Drug Alcohol Depend. 2007 Mar 16;87(2-3):153-63. doi: 10.1016/j.drugalcdep.2006.08.008. Epub 2006 Sep 20. Drug Alcohol Depend. 2007. PMID: 16987612 Free PMC article.
-
Adolescent and adult time trends in US hallucinogen use, 2002-19: any use, and use of ecstasy, LSD and PCP.Addiction. 2022 Dec;117(12):3099-3109. doi: 10.1111/add.15987. Epub 2022 Aug 17. Addiction. 2022. PMID: 35978453 Free PMC article.
-
Hallucinogen use among young adults ages 19-30 in the United States: Changes from 2018 to 2021.Addiction. 2023 Dec;118(12):2449-2454. doi: 10.1111/add.16259. Epub 2023 Jun 7. Addiction. 2023. PMID: 37287110
-
Adverse consequences of lysergic acid diethylamide.Addiction. 1993 Oct;88(10):1327-34. doi: 10.1111/j.1360-0443.1993.tb02018.x. Addiction. 1993. PMID: 8251869 Review.
-
[Hallucinogen-induced psychological disorders].Fortschr Neurol Psychiatr. 2008 Jun;76(6):334-42. doi: 10.1055/s-2008-1038191. Fortschr Neurol Psychiatr. 2008. PMID: 18512184 Review. German.
Cited by
-
Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.Drug Alcohol Depend. 2006 Sep 1;84(1):102-13. doi: 10.1016/j.drugalcdep.2006.01.002. Epub 2006 Feb 17. Drug Alcohol Depend. 2006. PMID: 16483730 Free PMC article.
-
Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact.Pharmaceuticals (Basel). 2020 Oct 23;13(11):334. doi: 10.3390/ph13110334. Pharmaceuticals (Basel). 2020. PMID: 33114119 Free PMC article. Review.
-
Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).Pharmacol Biochem Behav. 2012 Mar;101(1):69-76. doi: 10.1016/j.pbb.2011.12.002. Epub 2011 Dec 14. Pharmacol Biochem Behav. 2012. PMID: 22197710 Free PMC article.
-
Who is becoming hallucinogen dependent soon after hallucinogen use starts?Drug Alcohol Depend. 2007 Mar 16;87(2-3):153-63. doi: 10.1016/j.drugalcdep.2006.08.008. Epub 2006 Sep 20. Drug Alcohol Depend. 2007. PMID: 16987612 Free PMC article.
-
5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice.Neuropsychopharmacology. 2009 Jul;34(8):1958-67. doi: 10.1038/npp.2009.29. Epub 2009 Mar 25. Neuropsychopharmacology. 2009. PMID: 19322172 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
